Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2001Seminars in Cutaneous Medicine and Surgery

Pimecrolimus (Elidel, SDZ ASM 981)—Preclinical pharmacologic profile and skin selectivity

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAnton StuetzNovartis (Switzerland)MGMaximilian A. GrassbergerNovartis (Austria)JMJosef G. MeingassnerForschungs- und Beratungsstelle Arbeitswelt

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stuetz et al. (2001) studied this question.

synapsesocial.com/papers/6a7bb723073f483584df8886https://doi.org/10.1053/sder.2001.29066
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion1998 · 114 citations
  2. 2Ascomycins: promising agents for the treatment of inflammatory skin diseases2000 · 75 citations
  3. 3Anti-Inflammatory Effects of Macrophilin-lnteracting Drugs in Animal Models of Irritant and Allergic Contact Dermatitis2009 · 34 citations